Fixed-duration epcoritamab + R-CHOP induces high complete response rates in patients with previously untreated diffuse large B-cell lymphoma with high-risk features: Long-term results from the EPCORE NHL-2 trial Meeting Abstract
| Authors: | Falchi, L.; Offner, F.; de Vos, S.; Brody, J.; Cordoba, R.; Linton, K.; Snauwaert, S.; Clausen, M. R.; Oki, T.; Steele, A. J.; Hao, Y.; Archer, K. G.; Rana, A.; Belada, D. |
| Abstract Title: | Fixed-duration epcoritamab + R-CHOP induces high complete response rates in patients with previously untreated diffuse large B-cell lymphoma with high-risk features: Long-term results from the EPCORE NHL-2 trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 581 |
| End Page: | 582 |
| Language: | English |
| ACCESSION: | WOS:001414815800031 |
| DOI: | 10.1182/blood-2024-198023 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
